Abstract
The insulin receptor kinase (IRK) is a tyrosine kinase whose activation, subsequent to insulin binding, is essential for insulin-signalling in target tissues. Insulin binding to its cell surface receptor is rapidly followed by internalization of insulin-IRK complexes into the endosomal apparatus (EN) of the cell. Internalization of insulin into target organs, especially liver, is implicated in effecting insulin clearance from the circulation. Internalization mediates IRK downregulation and hence attenuation of insulin sensitivity although most internalized IRKs readily recycle to the plasma membrane at physiological levels of insulin. A role for internalization in insulin signalling is indicated by the accumulation of activated IRKs in ENs. Furthermore, the maximal level of IRK activation has been shown to exceed that attained at the cell surface. Using an in vivo rat liver model in which endosomal IRKs are exclusively activated has revealed that IRKs at this intracellular locus are able by themselves to promote IRS-1 tyrosine phosphorylation and induce hypoglycemia. Furthermore, studies with isolated rat adipocytes reveal the EN to be the principle site of insulin-stimulated IRS-1 tyrosine phosphorylation and associated PI3K activation. Key steps in the termination of the insulin signal are also operative in ENs. Thus, an endosomal acidic insulinase has been identified which limits the extent of IRK activation. Furthermore, IRK dephosphorylation is effected in ENs by an intimately associated phosphotyrosine phosphatase(s) which, in rat liver, appears to regulate IRK activity in both a positive and negative fashion. Thus, insulin-mediated internalization of IRKs into ENs plays a crucial role in effecting and regulating signal transduction in addition to modulating the levels of circulating insulin and the cellular concentration of IRK in target tissues. (Mol Cell Biochem 182: 59-63, 1998)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kahn CR, Freychet P, Roth J, Neville D Jr: Quantitative aspects of the insulin-receptor interaction in liver plasma membranes. J Biol Chem 249: 2249–2257, 1974
Jaspan JB, Polonsky KS, Lewis M, Pensler J, Pugh W, Moossa AR, Rubenstein AH: Hepatic metabolism of glucagon in the dog: Contribution of the liver to overall metabolic disposal of glucagon. Am JPhysiol 240: E233–E244, 1981
Bergeron JJM, Sikstrom R, Hand AR, Posner BI: Binding and uptake of 125I-insulin into rat liver hepatocytes and endothelium. An in vivo radioautographic study. J Cell Biol 80: 427–443, 1979
Burgess JW, Bevan AP, Bergeron JJM, Posner BI: Intracellular trafficking and processing of ligand receptor complexes in the endosomal system. Exp Clin Endocrinol 11: 67–78, 1992
Bergeron JJM, Cruz J, Khan MN, Posner BI: Uptake of insulin and other ligands into receptor-rich endocytic components of target cells: the endosomal apparatus. Ann Rev Physiol 47: 383–403. 1985
Wall DA, Hubbard AL: Receptor-mediated endocytosis of asialoglycoproteins by rat liver hepatocytes: Biochemical characterization ofthe endosomal compartments. J Cell Biol 101: 2104–2112, 1985
Mellman 1, Fuchs R, Helenius A: Acidification of the endocytic and exocytic pathways. Ann Rev Biochem 55: 663–700, 1986
Lai WH, Cameron PH, Wada I, Doherty JJ II, Kay DC, Posner BI, Bergeron JJM: Ligand-mediated internalization, recycling, and downregulation of the epidermal growth factor receptor in vivo. J Cell Biol 109: 2741–2749, 1989
Dunn WA, Hubbard AL: Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver Ligand and receptor dynamics. J Cell Biol 98: 2148–2159, 1984
Doherty JJ II, Kay DG, Lai WH, Posner BI, Bergeron JJM: Selective degradation of insulin within rat liver endosomes. J Cell Biol 110: 35–42, 1990
Backer JM, Kahn CR, White MF: The dissociation and degradation of internalized insulin occur in the endosomes of rat hepatoma cells. J Biol Chem 265: 14828–14835, 1990
Authier F, Rachubinski RA, Posner BI, Bergeron JJM: Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. J Biol Chem 269: 3010–3016, 1994
Authier F, Bergeron JJM, Ou WJ, Rachubinski RA, Posner BI, Walton PA: Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase. Proc Natl Acad Sci USA 92: 3859–3863, 1995
Authier F, Posner BI, Bergeron JJM: Insulin-degrading enzyme. Clin Invest Med 19: 149–160, 1996
Rosen OM, Herrera R, Olowe Y, Petruzzelli LM, Cobb MH: Phos-phorylation activates the IR tyrosine protein kinase. Proc Natl Acad Sci USA 80: 3237–3240, 1983
Sale G: Serine/threonine kinases and tyrosine phosphatases that act on the insulin receptor. Biochem Soc Trans 20: 664–670, 1992
King MJ, Sale GJ: Insulin-receptor phosphotyrosyl-protein phosphatases. Biochem J 256: 893–902, 1988
Ahmad F, Goldstein BJ: Purification, identification and subcellular distribution of three predominant protein-tyrosine Phosphatase enzymes in skeletal muscle tissue. Biochim Biophys Acta 1248: 57–69, 1995
Meyerovitch J, Backer JM, Csermely P, Shoelson SE, Kahn CR: Insulin differentially regulates protein phosphotyrosine Phosphatase activity in rat hepatoma cells. Biochem 31: 10338–10344, 1992
Faure R, Baquiran G, Bergeron JJM, Posner BI: The dephosphorylation of insulin and epidermal growth factor receptors. The role of endosome-associated phosphotyrosine phosphatase(s). J Biol Chem 267: 11215–11221, 1992
Bevan AP, Drake PG, Yale J-F, Shaver A, Posner BI: Peroxovanadium compounds: Biological actions and mechanism of insulin-mimesis. Mol Cell Biochem 153: 49–58, 1995
Posner BI, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JN, Hall DA, Soo Lum B, Shaver A: Peroxovanadium compounds. A new class of potent phosphotyrosine Phosphatase inhibitors which are insulin mimetics. J Biol Chem 269: 4596–4604, 1994
Bevan AP, Burgess JW, Yale J-F, Drake PG, Lachance D, Baquiran G, Shaver A, Posner BI: In vivo insulin mimetic effects of pV compounds: Role for tissue targeting in determining potency. Am J Physiol 268: E60–E66, 1995
Drake PG, Bevan AP, Burgess JW, Bergeron JJM, Posner BI: A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo. Endocrinology 137: 4960–4968, 1996
Bevan AP, Burgess JW, Drake PG, Shaver A, Bergeron JJM, Posner BI: Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signalling. J Biol Chem 270: 10784–10791, 1995
Khan MN, Baquiran G, Brule C, Burgess J, Foster B, Bergeron JJM, Posner BI: Internalization and activation of the rat liver insulin receptor kinase in vivo. Biol Chem 264: 12931–12940, 1989
Backer JM, Kahn CR, White MF: Tyrosine phosphorylation of the insulin receptor during insulin-stimulated internalization in rat hepatoma cells. J Biol Chem 264: 1694–1701, 1989
Klein HH, Freidenberg GR, Matthaei S, Olefsky JM: Insulin receptor kinase following internalization in isolated rat adipocytes. J Biol Chem 262: 10557–10564, 1987
Kublaoui B, Lee J, Pilch PF: Dynamics of signalling during insulinstimulated endocytosis of its receptor in adipocytes. J Biol Chem 270: 59–65, 1995
Burgess JW, Wada I, Ling N, Khan MN, Bergeron JJM, Posner BI: Decrease in β-subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin receptor kinase. J Biol Chem 267: 10077–10086, 1992
Bemier M, Llotta AS, Kole HK, Shock DD, Roth J: Dynamic regulation of intact and C-terminal truncated insulin receptor phosphorylation in permeablized cells. Biochem 33: 4343–4351, 1994
Tavare JM, Ramos P, Ellis L: An assessment of human insulin receptor phosphorylation and exogenous kinase activity following deletion of 69 residues from the carboxy-terminus of the receptor b-subunit. Biochem Biophys Res Comm 188: 86–93, 1992
Kaliman P, Baron V, Alengrin F, Takata Y, Webster NJG, Olefsky JM, Van Obberghen E: The insulin receptor C-terminus is involved in the regulation of the receptor kinase activity. Biochemistry 32: 9539–9544, 1993
Baass PC, Di Guglielmo GM, Authier F, Posner BI, Bergeron JJM: Compartmentalized signal transduction by receptor tyrosine kinases. Trends Cell Biol 5: 465–470, 1995
Bevan AP, Drake PG, Bergeron JJM, Posner BI: Intracellular signal transduction-The role of endosomes. Trends Endocrinol Metab 7: 13–21, 1996
Di Guglielmo GM, Baass PC, Ou WJ, Posner BI, Bergeron JJM: Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J 13: 4269–4277, 1994
Vieira AV, Lamaze C, Schmid SL: Control of EGF receptor signalling by clathrin-mediated endocytosis. Science 274: 2086–2089, 1996
Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M: Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signalling. Cell 78: 1005–1015, 1994
Khan MN, Savoie S, Bergeron JJM, Posner BI: Characterization of rat liver endosomal structures. In vivo activation of insulin-stimulable receptor kinase in these structures. J Biol Chem 261: 8462–8472, 1986
Wang B, Balba Y, Knutson VP: Insulin-induced in situ phosphorylation of the insulin receptor located in the plasma membrane versus endosomes. Biochem Biophys Res Comm 227: 27–34, 1996
Kelly KL, Ruderman NB: Insulin-stimulated phosphatidylinositol 3-kinase: Association with a 185 kDa tyrosine phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem 268: 4391–4398, 1993
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Guglielmo, G.M.D., Drake, P.G., Baass, P.C., Authier, F., Posner, B.I., Bergeron, J.J. (1998). Insulin receptor internalization and signalling. In: Srivastava, A.K., Posner, B.I. (eds) Insulin Action. Developments in Molecular and Cellular Biochemistry, vol 24. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5647-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5647-3_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7584-5
Online ISBN: 978-1-4615-5647-3
eBook Packages: Springer Book Archive